Dr. Clay Siegall is a famous businessman in the field of medical health. He is well known for manufacturing drugs that cure resistant illness. He is the founder of the Seattle genetics company. He is the CEO of the enterprise. Dr. Clay is portrayed as an amazing philanthropist. In connection to this, he has demonstrated a great sense of generosity by donating more than 1.2 billion Dollars to the public as well as the private sectors.
His achievements saw him receive the University of Maryland alumnus of the year in various subjects. He won the award in the year 2012. One year later; Dr. Clay was recognized as the Pacific Northwest Ernst and Young Entrepreneur of the year.
Dr. Clay Siegall acquired his academic qualification as a foundation to his success. This saw him attend the University of Washington for a Ph.D. in genetics. He also received academic qualification on Zoology in which he graduated with a B.S. from the University of Maryland. Siegall founded the Seattle genetics company in the year 1998. Recent news confirms that the Company is a perfect icon in matters relating to medical health since it continues to do manufacture effective drugs that cure resistant illnesses.
With the impact of Dr. Clay’ vast experience, the company has managed to make cancer drugs. Siegall has acquired much of his experience through pressing engagements in doing research. With his incredible passion in research, he has successfully obtained viable findings in various areas of concern. Among so many drugs manufacturing companies, Seattle has been rated one of the best globally. This is according to a recent study. The company is still under the leadership of Clay up-to-date serving to the President as well as the CEO capacity. He has developed more than twenty years of experience serving the company at a managerial level. His career began with him serving as the senior research investigator at the Bristol-Myers Squibb Pharmaceutical Research Institute. Clay has continued cancer patients around the world. This has earned him an excellent reputation among the cancer patients.